Clinical Trial Detail

NCT ID NCT02983578
Title AZD9150 With MEDI4736 in Patients With Advanced Pancreatic, Non-Small Lung and Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

pancreatic cancer

lung non-small cell carcinoma

colorectal cancer

Therapies

AZD9150 + Durvalumab

Age Groups: adult senior

No variant requirements are available.